StonvexLoading…
StonvexStonvexStonvexCore line items from ESAB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.84B | $2.74B | $2.77B | $2.59B |
Operating Income | $412.17M | $447.45M | $404.17M | $329.06M |
Net Income | $226.77M | $264.84M | $205.28M | $223.75M |
EPS (Diluted) | $3.67 | $4.31 | $3.36 | $3.69 |
Total Assets | $4.77B | $4.03B | $3.83B | $3.75B |
Total Liabilities | $2.55B | $2.23B | $2.18B | $2.37B |
Cash & Equivalents | $185.86M | $249.36M | $102.00M | $72.02M |
Free Cash Flow OCF − CapEx | $213.28M | $303.62M | $282.32M | $174.12M |
Shares Outstanding | 60.72M | 60.52M | 60.30M | 60.09M |